BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Free cash flow, 2025
- $3.7B
- YoY, 2025
- +38.3%
- 5-year CAGR
- +26.4%
- 10-year CAGR
- +23.5%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $3.7B | +38.3% |
| 2024 | $2.6B | +47.6% |
| 2023 | $1.8B | +91.0% |
| 2022 | $938M | −28.7% |
| 2021 | $1.3B | +16.3% |
| 2020 | $1.1B | −17.7% |
| 2019 | $1.4B | — |
| 2018 | −$6.0M | — |
| 2017 | $1.1B | +37.3% |
| 2016 | $806M | +81.5% |
| 2015 | $444M | −56.0% |
| 2014 | $1.0B | +16.8% |
| 2013 | $865M | −17.9% |
| 2012 | $1.1B | +49.7% |
| 2011 | $704M | +1,228.3% |
| 2010 | $53M | −89.9% |
| 2009 | $523M | −38.8% |
| 2008 | $854M | +49.6% |
| 2007 | $571M | — |